| Treatment of glioblastoma (GBM) with the addition of tumor-treating fields (TTF): a review D Fabian, MP Guillermo Prieto Eibl, I Alnahhas, N Sebastian, P Giglio, ... Cancers 11 (2), 174, 2019 | 197 | 2019 |
| Tumor lysis syndrome: a systematic review of case series and case reports BM Firwana, R Hasan, N Hasan, F Alahdab, I Alnahhas, S Hasan, J Varon Postgraduate medicine 124 (2), 92-101, 2012 | 55 | 2012 |
| Undergraduate medical students’ perceptions, attitudes, and competencies in evidence-based medicine (EBM), and their understanding of EBM reality in Syria F Alahdab, B Firwana, R Hasan, MB Sonbol, M Fares, I Alnahhas, ... BMC research notes 5, 1-7, 2012 | 49 | 2012 |
| Characterizing benefit from temozolomide in MGMT promoter unmethylated and methylated glioblastoma: a systematic review and meta-analysis I Alnahhas, M Alsawas, A Rayi, JD Palmer, R Raval, S Ong, P Giglio, ... Neuro-oncology advances 2 (1), vdaa082, 2020 | 46 | 2020 |
| Autologous stem-cell transplantation for primary central nervous system lymphoma: systematic review and meta-analysis I Alnahhas, M Jawish, M Alsawas, A Zukas, L Prokop, MH Murad, ... Clinical Lymphoma Myeloma and Leukemia 19 (3), e129-e141, 2019 | 41 | 2019 |
| A case of new-onset antibody-positive myasthenia gravis in a patient treated with pembrolizumab for melanoma. I Alnahhas, J Wong Muscle & Nerve 55 (6), E25-E26, 2017 | 39 | 2017 |
| Scalp-sparing radiation with concurrent temozolomide and tumor treating fields (SPARE) for patients with newly diagnosed glioblastoma R Miller, A Song, A Ali, M Niazi, V Bar-Ad, N Martinez, J Glass, I Alnahhas, ... Frontiers in oncology 12, 896246, 2022 | 21 | 2022 |
| Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE. 6 (EORTC 26062-22061, TROG08. 02) randomized clinical trial AJ Song, K Ding, I Alnahhas, NJ Laperriere, J Perry, WP Mason, C Winch, ... Neuro-oncology advances 3 (1), vdab153, 2021 | 11 | 2021 |
| Prognostic implications of epidermal and platelet-derived growth factor receptor alterations in 2 cohorts of IDHwt glioblastoma I Alnahhas, A Rayi, MP Guillermo Prieto Eibl, S Ong, P Giglio, V Puduvalli Neuro-Oncology Advances 3 (1), vdab127, 2021 | 9 | 2021 |
| Assessment of leptomeningeal carcinomatosis diagnosis, management and outcomes in patients with solid tumors over a decade of experience H Rinehardt, M Kassem, E Morgan, M Palettas, JA Stephens, A Suresh, ... European Journal of Breast Health 17 (4), 371, 2021 | 7 | 2021 |
| Management of gliomas in patients with Lynch syndrome I Alnahhas, A Rayi, S Ong, P Giglio, V Puduvalli Neuro-oncology 23 (1), 167-168, 2021 | 6 | 2021 |
| Concurrent chemoradiation and Tumor Treating Fields (TTFields, 200 kHz) for patients with newly diagnosed glioblastoma: patterns of progression in a single institution pilot study AS Ali, J Lombardo, MZ Niazi, RC Miller, I Alnahhas, NL Martinez, ... Journal of Neuro-Oncology 160 (2), 345-350, 2022 | 5 | 2022 |
| The role of VEGF receptor inhibitors in preventing cerebral radiation necrosis: a retrospective cohort study I Alnahhas, A Rayi, JD Palmer, R Raval, E Folefac, S Ong, P Giglio, ... Neuro-Oncology Practice 8 (1), 75-80, 2021 | 5 | 2021 |
| False-positive 1p/19q testing results in gliomas: clinical and research consequences I Alnahhas, A Rayi, D Thomas, S Ong, P Giglio, V Puduvalli American Journal of Clinical Oncology 43 (11), 802-805, 2020 | 5 | 2020 |
| Targeted Therapy for BRAF Mutant Brain Tumors A Rayi, I Alnahhas, S Ong, P Giglio, VK Puduvalli Current treatment options in oncology 22, 1-14, 2021 | 4 | 2021 |
| Changing paradigms for targeted therapies against diffuse infiltrative gliomas: tackling a moving target CD Carpenter, I Alnahhas, J Gonzalez, P Giglio, VK Puduvalli Expert review of neurotherapeutics 19 (7), 663-677, 2019 | 4 | 2019 |
| Journal Club: Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma I Alnahhas, M Malkin Neurology 85 (24), e187-e189, 2015 | 4 | 2015 |
| Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review. Cancers (Basel)(2019) D Fabian, MDPGP Eibl, I Alnahhas, N Sebastian, P Giglio, V Puduvalli, ... | 3 | |
| Differences in clinical outcomes based on molecular markers in glioblastoma patients treated with concurrent tumor-treating fields and chemoradiation: exploratory analysis of … L Cappelli, MM Khan, A Kayne, S Poiset, R Miller, A Ali, MK Niazi, W Shi, ... | 2 | 2023 |
| An evaluation of MGMT promoter methylation within the methylation subclasses of glioblastoma I Alnahhas, S LaHaye, P Giglio, E Mardis, V Puduvalli Neuro-Oncology Advances 2 (1), vdaa117, 2020 | 2 | 2020 |
